| SNAP23 |
SNAP23: Synaptosomal-associated protein 23 |
EPIM |
STX2, EPIM, STX2A, STX2B, STX2C: Syntaxin-2 |
6.702 |
Evidence |
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB13 |
RAB13, GIG4: Ras-related protein Rab-13 |
6.69 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
CDH5 |
CDH5: Cadherin-5 precursor |
6.685 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
6.685 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
6.685 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
6.685 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
IGFBP5 |
IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor |
6.685 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
6.685 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
PRKAA1 |
IPI00011891 |
6.685 |
Evidence |
|
| RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
6.682 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
6.682 |
Evidence |
|
| OXSR1 |
OXSR1, KIAA1101, OSR1: Serine/threonine-protein kinase OSR1 |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
6.682 |
Evidence |
|
| LMNA |
LMNA, LMN1: Lamin-A/C |
LMNB1 |
LMNB1, LMN2, LMNB: Lamin-B1 |
6.68 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
6.672 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SRPK2 |
SRPK2: Serine/threonine-protein kinase SRPK2 |
6.672 |
Evidence |
|
| MOS |
MOS: Proto-oncogene serine/threonine-protein kinase mos |
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
6.672 |
Evidence |
|
| TOM1L1 |
TOM1L1, SRCASM: TOM1-like protein 1 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
6.672 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
6.672 |
Evidence |
|
| WDR54 |
IPI00029811 |
LSM5 |
LSM5: U6 snRNA-associated Sm-like protein LSm5 |
6.662 |
Evidence |
|
| PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
CNN2 |
CNN2: Calponin-2 |
6.662 |
Evidence |
|
| U2AF1 |
U2AF1, U2AF35, U2AFBP: Splicing factor U2AF 35 kDa subunit |
SF1 |
SF1, ZFM1, ZNF162: Splicing factor 1 |
6.662 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
6.66 |
Evidence |
|
| CREBBP |
CREBBP, CBP: CREB-binding protein |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
6.66 |
Evidence |
|
| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
6.66 |
Evidence |
|
| STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
6.66 |
Evidence |
|
-